Literature DB >> 9017202

Interaction of bee venom melittin with zwitterionic and negatively charged phospholipid bilayers: a spin-label electron spin resonance study.

J H Kleinschmidt1, J E Mahaney, D D Thomas, D Marsh.   

Abstract

Electron spin resonance (ESR) spectroscopy was used to study the penetration and interaction of bee venom melittin with dimyristoylphosphatidylcholine (DMPC) and ditetradecylphosphatidylglycerol (DTPG) bilayer membranes. Melittin is a surface-active, amphipathic peptide and serves as a useful model for a variety of membrane interactions, including those of presequences and signal peptides, as well as the charged subdomain of the cardiac regulatory protein phospholamban. Derivatives of phosphatidylcholine and phosphatidylglycerol spin-labeled at various positions along the sn-2 acyl chain were used to establish the chain flexibility gradient for the two membranes in the presence and absence of melittin. Negatively charged DTPG bilayer membranes showed a higher capacity for binding melittin without bilayer disruption than did membranes formed by the zwitterionic DMPC, demonstrating the electrostatic neutralization of bound melittin by DTPG. The temperature dependence of the ESR spectra showed that the gel-to-liquid crystalline phase transition is eliminated by binding melittin to DTPG bilayers, whereas a very broad transition remains in the case of DMPC bilayers. None of the spin labels used showed a two-component spectrum characteristic of a specific restriction of their chain motion by melittin, but the outer hyperfine splittings and effective chain order parameters were increased for all labels upon binding melittin. This indicates a reduced flexibility of the lipid chains induced by a surface orientation of the bound melittin. Whereas the characteristic shape of the chain flexibility gradient was maintained upon melittin addition to DMPC bilayers, the chain flexibility profile in DTPG bilayers was much more strongly perturbed. It was found that the steepest change in segmental flexibility was shifted toward the bilayer interior when melittin was bound to DTPG membranes, indicating a greater depth of penetration than in DMPC membranes. pH titration of stearic acid labeled at the C-5 position, used as a probe of interfacial interactions, showed net downward shifts in interfacial pK of 0.8 and 1.2 pH units contributed from the positive charge of melittin, outweighing upward shifts from interfacial dehydration, when melittin was bound to DTPG and DMPC, respectively. The perturbation of the outer hyperfine splitting was used to determine the interactions of melittin with spin-labeled lipids of different polar headgroups in DTPG and DMPC. Anionic lipids (phosphatidylserine, phosphatidylglycerol, and stearic acid) and zwitterionic lipids (phosphatidylethanolamine and phosphatidylcholine) had the largest outer splittings in the presence of melittin. Neutral lipids (protonated stearic acid and diacylglycerol) displayed the largest increase in outer splitting on binding melittin, which was attributed to a change in the vertical location of these lipids in the bilayer. Both effects were more pronounced in DTPG than in DMPC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9017202      PMCID: PMC1185600          DOI: 10.1016/s0006-3495(97)78711-3

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  45 in total

1.  Phospholamban is related to the autoinhibitory domain of the plasma membrane Ca(2+)-pumping ATPase.

Authors:  M Chiesi; T Vorherr; R Falchetto; C Waelchli; E Carafoli
Journal:  Biochemistry       Date:  1991-08-13       Impact factor: 3.162

2.  A combined study of aggregation, membrane affinity and pore activity of natural and modified melittin.

Authors:  S Stankowski; M Pawlak; E Kaisheva; C H Robert; G Schwarz
Journal:  Biochim Biophys Acta       Date:  1991-10-14

3.  Mechanism of Ca-ATPase inhibition by melittin in skeletal sarcoplasmic reticulum.

Authors:  J C Voss; J E Mahaney; D D Thomas
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

4.  Electron spin resonance study of phospholipid membranes employing a comprehensive line-shape model.

Authors:  A Lange; D Marsh; K H Wassmer; P Meier; G Kothe
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

5.  The self-association of melittin and its binding to lipids: an intrinsic fluorescence polarization study.

Authors:  J F Faucon; J Dufourcq; C Lussan
Journal:  FEBS Lett       Date:  1979-06-01       Impact factor: 4.124

6.  Lipid spin labels in lecithin multilayers. A study of motion along fatty acid chains.

Authors:  P Jost; L J Libertini; V C Hebert; O H Griffith
Journal:  J Mol Biol       Date:  1971-07-14       Impact factor: 5.469

7.  The spontaneous insertion of proteins into and across membranes: the helical hairpin hypothesis.

Authors:  D M Engelman; T A Steitz
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

8.  The orientation of melittin in lipid membranes. A polarized infrared spectroscopy study.

Authors:  H Vogel; F Jähnig; V Hoffmann; J Stümpel
Journal:  Biochim Biophys Acta       Date:  1983-09-07

9.  Protein surface-distribution and protein-protein interactions in the binding of peripheral proteins to charged lipid membranes.

Authors:  T Heimburg; D Marsh
Journal:  Biophys J       Date:  1995-02       Impact factor: 4.033

10.  Melittin induces HII phase formation in cardiolipin model membranes.

Authors:  A M Batenburg; J C Hibbeln; A J Verkleij; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1987-09-18
View more
  17 in total

1.  Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes.

Authors:  Raanan Carmieli; Niv Papo; Herbert Zimmermann; Alexey Potapov; Yechiel Shai; Daniella Goldfarb
Journal:  Biophys J       Date:  2005-10-28       Impact factor: 4.033

2.  On the mechanism of pore formation by melittin.

Authors:  Geert van den Bogaart; Jeanette Velásquez Guzmán; Jacek T Mika; Bert Poolman
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

3.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Rohan Bhavane; Stefania Acciardo; Francesco Salvatore; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

4.  Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

Authors:  P Pollesello; A Annila; M Ovaska
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

5.  Spin-label electron spin resonance studies on the interactions of lysine peptides with phospholipid membranes.

Authors:  J H Kleinschmidt; D Marsh
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

6.  ADP ribosylation factor 6 binding to phosphatidylinositol 4,5-bisphosphate-containing vesicles creates defects in the bilayer structure: an electron spin resonance study.

Authors:  M Ge; J S Cohen; H A Brown; J H Freed
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

7.  Defects in vesicle core induced by escherichia coli dihydroorotate dehydrogenase.

Authors:  Sheila G Couto; M Cristina Nonato; Antonio J Costa-Filho
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

8.  Structural transitions in short-chain lipid assemblies studied by (31)P-NMR spectroscopy.

Authors:  Jörg H Kleinschmidt; Lukas K Tamm
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

9.  Lipid binding and membrane penetration of polymyxin B derivatives studied in a biomimetic vesicle system.

Authors:  Marina Katz; Haim Tsubery; Sofiya Kolusheva; Alex Shames; Mati Fridkin; Raz Jelinek
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

10.  Effect of micellar charge on the conformation and dynamics of melittin.

Authors:  H Raghuraman; Amitabha Chattopadhyay
Journal:  Eur Biophys J       Date:  2004-04-08       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.